Keyphrases
Type 1 Diabetes Mellitus (T1DM)
100%
Type I Diabetes
80%
Hypoglycemia
59%
Type 2 Diabetes Mellitus (T2DM)
38%
Glycemic Control
35%
Children with Type 1 Diabetes
34%
Glucagon
31%
Young children
31%
Hemoglobin A1c (HbA1c)
29%
Diabetes
25%
Insulin
25%
Plasma Glucose
24%
Cystic Fibrosis
22%
Hyperglycemia
21%
Counterregulatory Response
18%
Continuous Glucose Monitoring
18%
Treatment Options
17%
Body Mass Index
15%
Non-diabetic
15%
Cell Function
15%
Adrenal Insufficiency
14%
Brain Function
14%
Brain Development
13%
Hypoglycemia-associated Autonomic Failure
13%
High-density Diffuse Optical Tomography
13%
Insulin Secretion
13%
Epinephrine
13%
Positron Emission Tomography
12%
White Matter Volume
12%
Body Composition
11%
Glycemia
11%
White Matter
11%
Longitudinal Assessment
11%
Insulin Therapy
11%
Clinical Presentation
10%
Diabetic Ketoacidosis
10%
Youth Studies
10%
Glucose Level
10%
Obesity
10%
Older Adults
9%
Metformin
9%
Insulin Sensitivity
9%
Control Subjects
9%
Gray Matter Volume
9%
Cortisol Assay
8%
Elexacaftor-tezacaftor-ivacaftor
8%
Resistance Training
8%
Brain Volume
8%
Memory Function
8%
Clinical Trials
8%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
31%
Hypoglycemia
25%
Insulin Dependent Diabetes Mellitus
23%
Glycemic Control
23%
Diabetes
18%
Diabetes in Adolescents
16%
Cystic Fibrosis
14%
Adrenal Insufficiency
14%
Hemoglobin A1c
14%
Body Mass Index
13%
Positron Emission Tomography
10%
Pediatrics
9%
COVID-19
8%
Hydrocortisone
8%
Optical Tomography
8%
Resistance Training
8%
Clinical Trial
8%
Glycon
8%
Type 1 Diabetes
7%
Diabetes Mellitus
7%
Insulin Sensitivity
6%
Brain Function
6%
Diseases
6%
Brain Development
6%
Insulin Treatment
5%
Comorbidity
5%
Glucose Metabolism
5%